Valley Capital Investment Orca Bio Raises $192M Series D for Cell Therapies
Menlo Park, California-based Orca Bio closed on a Series D financing worth $192 million, bringing the total raised since 2016 to $300 million. The round was co-led by Lightspeed Venture Partners and an undisclosed investor. New and existing investors included 8VC, DCVC Bio, ND Capital, Mubadala Investment Company, Kaiser Foundation Hospitals, Kaiser Permanente Group Trust and IMRF. […]
Valley Capital Investment Orca Bio Raises $192M Series D for Cell Therapies Read More »